Announced Wed, 15 Jul · 11:58 IST
NephroPlus allots 2.18 lakh shares under ESOP Scheme 2011
Capital Market Events View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹640.30
prior close
₹649.75
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.3-0.2+0.0-0.2-0.1-1.5-2.1+5.2+5.6————
Up moveDown movePending
AI summary
Nephrocare Health Services (NephroPlus) allotted 2,18,297 equity shares of face value Rs. 2 each under its ESOP Scheme 2011, following stock option exercises by eligible employees. The Nomination and Remuneration Committee approved this on July 14, 2026. Total money raised was about Rs. 2.08 crore. Post-allotment, total shares stand at 10,05,59,014 and share capital at about Rs. 20.11 crore. New shares rank equally with existing equity shares.
Likely market impact
Minor dilution from routine ESOP exercise. About 0.22 percent increase in share count. Neutral impact for existing shareholders.